Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality. Read More
Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors,… Read More
Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software. The project, called… Read More
